• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 467630 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414138551 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414138551 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Sell Off Shares of Ligand Pharmaceuticals, Down 1.6%

Published on Wed, 03/27/2013 - 10:29
By Adrienne Chilton

One of today's notable stocks in decline is Ligand Pharmaceuticals (NASDAQ:LGND), down 1.6% to $25.66. The Dow is down 0.4% to 14,507 and the S&P is currently down 0.3% to 1,558.

Ligand Pharmaceuticals (NASDAQ:LGND) has potential upside of 11.5% based on a current price of $25.66 and analysts' consensus price target of $28.60. Ligand Pharmaceuticals shares have support at the 50-day moving average (MA) of $21.47 and additional support at the 200-day MA of $18.57.

Over the past year, Ligand Pharmaceuticals has traded in a range of $11.21 to $26.33 and is now at $25.66, 129% above that low. Over the past week, the 200-day moving average (MA) has gone up 1.1% while the 50-day MA has advanced 1.6%.

Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of Susquehanna Bancshares Fall Be...

Susquehanna Bancshares (NASDAQ:SUSQ) traded at a new 52-week low today of $9.37. So fa ...

Watch for Continued Losses in Shares of ...

Shares of Seachange International (NASDAQ:SEAC) traded today at $6.56, breaking its 52- ...

Select Comfort Looks to Continue to Trad...

Select Comfort (NASDAQ:SCSS) traded today at a new 52-week high of $25.70. This new hi ...

Shares of Paramount Gold and Silver Have...

Paramount Gold and Silver (NYSE:PZG) traded today at a new 52-week low of $0.66. Appro ...

Shares of Precision Castparts Have Falle...

Precision Castparts (NYSE:PCP) traded today at a new 52-week low of $215.09. So far to ...

Watch for Continued Losses in Shares of ...

New Gold (AMEX:NGD) traded today at a new 52-week low of $4.20. Approximately 2.3 mill ...

Shares of Micron Technology Have Risen A...

Micron Technology (NASDAQ:MU) traded at a new 52-week high today of $31.37. This new h ...

Watch for Continued Gains in Shares of M...

Monster Worldwide (NASDAQ:MNST) traded at a new 52-week high today of $99.53. Approxim ...